(Q51379514)

4 April 2018

title

Enhanced functional stability of plasminogen activator inhibitor-1 in patients with livedoid vasculopathy. (English)

1 reference

4 April 2018

author name string

Mehmet Agirbasli

1

1 reference

4 April 2018

Mesut Eren

2

1 reference

4 April 2018

Fatih Eren

3

1 reference

4 April 2018

Sheila B Murphy

4

1 reference

4 April 2018

Zehra A Serdar

5

1 reference

4 April 2018

Dilek Seckin

6

1 reference

4 April 2018

Tuba Zara

7

1 reference

4 April 2018

M Cem Mat

8

1 reference

4 April 2018

Cuyan Demirkesen

9

1 reference

4 April 2018

Douglas E Vaughan

10

1 reference

4 April 2018

publication date

1 July 2011

1 reference

4 April 2018

Journal of Thrombosis and Thrombolysis

published in

1 reference

4 April 2018

volume

32

1 reference

4 April 2018

issue

1

1 reference

4 April 2018

page(s)

59-63

1 reference

4 April 2018

https://scigraph.springernature.com/pub.10.1007/s11239-011-0556-y

exact match

0 references

cites work

Difficult management of livedoid vasculopathy

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0556-Y

Livedoid vasculopathy: further evidence for procoagulant pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0556-Y

Treatment of livedoid vasculopathy with low-molecular-weight heparin: report of 2 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0556-Y

Livedoid vasculopathy in a patient with factor V mutation (Leiden).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0556-Y

Livedoid vasculitis: a manifestation of the antiphospholipid syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0556-Y

Livedo (livedoid) vasculitis and the factor V Leiden mutation: additional evidence for abnormal coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0556-Y

PAI-1 and atherothrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0556-Y

Pivotal role of plasminogen-activator inhibitor 1 in vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0556-Y

Engineering plasminogen activator inhibitor 1 mutants with increased functional stability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0556-Y

Interactive effect of PAI-1 4G/5G genotype and salt intake on PAI-1 antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0556-Y

Age-dependent spontaneous coronary arterial thrombosis in transgenic mice that express a stable form of human plasminogen activator inhibitor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0556-Y

Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0556-Y

Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0556-Y

Potential roles of plasminogen activator system in coronary vascular remodeling induced by long-term nitric oxide synthase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0556-Y

Tissue-specific PAI-1 gene expression and glycosylation pattern in insulin-resistant old rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0556-Y

Interaction among 5,10 methylenetetrahydrofolate reductase, plasminogen activator inhibitor and endothelial nitric oxide synthase gene polymorphisms predicts the severity of coronary artery disease in Turkish patients

21 January 2018

1 reference

12 December 2020

Tissue plasminogen activator for treatment of livedoid vasculitis

1 reference

12 December 2020

Mixed connective tissue disease associated with skin defects of livedoid vasculitis

1 reference

12 December 2020

Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity

1 reference

12 December 2020

Livedo vasculopathy vs small vessel cutaneous vasculitis: cytokine and platelet P-selectin studies

1 reference

12 December 2020

Molecular evolution of plasminogen activator inhibitor-1 functional stability

1 reference

12 December 2020

Livedoid vasculopathy: what is it?

1 reference

12 December 2020

Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator

1 reference

12 December 2020

Livedoid vasculopathy associated with heterozygous protein C deficiency

1 reference

12 December 2020

"Idiopathic" white atrophy

1 reference

12 December 2020

10.1007/S11239-011-0556-Y

Identifiers

DOI

1 reference

4 April 2018

release_smsdrvltwfekhbqmx3xydrcpjm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/smsdrvltwfekhbqmx3xydrcpjm

24 November 2022

mapped directly with Wikidata item

1 reference

4 April 2018